Echo Pharmaceuticals is a company specialised in cannabinoids aiming to meet patient needs in a wide range of therapeutic areas. Our clinical development programs focus on MS, Epilepsy, Nausea and Pain, with our leading products Namisol® (oral tablet containing pure THC), and Arvisol® (oral tablet containing CBD). Our drug delivery technologies, including the novel lipophilic compound delivery technology, Alitra™ can be applied to any cannabinoid.
     
home1.jpg
                      
home2.jpg

Echo News

05/01/16 Echo is visiting JPM Healthcare Conference 2016 in San Francisco from the 11th till 14th of January Echo Pharmaceuticals is visiting the JP Morgan 34th Healthc... more

19/08/15 Clinical data reassures safety and tolerability of THC-based medicine Namisol® Clinical data reassures safety and tolerability of THC-ba... more

27/07/15 Improved uptake of cannabinoid based medicine ... more

In the Spotlight

Dementerenden kunnen snel aan wietpil.
(source: www.Gelderlander.nl)
NIJMEGEN - Ouderen met dementie kunnen waarschijnlijk snel aan de ‘wietpil’, een nieuw medicijn met het rustgevende cannabis. Voorlopige resultaten uit lopend onderzoek in het UMC St Radboud...

To read the whole article,click link:

http://www.gelderlander.nl/regio/nijmegen/dementerenden-kunnen-snel-aan-wietpil-1.3686470?